Marta Barretta

ORCID: 0000-0002-9045-9397 · 5 papers in corpus · active 2020-2025

Study types

  • article 2
  • review 2
  • other 1

Condition tags

  • endometriosis 4
  • adenomyosis 2
  • irritable_bowel_syndrome 1
article 2025
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2025.2589998

Endometriosis is a common, chronic disease with a high burden for women, characterised by the implantation of endometrial cells outside the uterus. Many different treatments have been proposed for this disease, mainly hormonal, with the obj…

other 2025
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2025.2514746

BACKGROUND: This is the first report aimed to evaluate the clinical impact and safety of sequential treatment with relugolix combination therapy (relugolix CT) in women with symptomatic uterine fibroids that were inadequately managed with 5…

review 2024
Expert opinion on drug metabolism & toxicology ·doi:10.1080/17425255.2024.2441981

INTRODUCTION: In ovarian steroid-dependent diseases such as uterine fibroids, endometriosis and adenomyosis, oral GnRH antagonists have emerged as new therapeutic alternatives. These oral GnRH antagonists offer key advantages, including ora…

article 2022
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13602

PROBLEM: Starting from November 2019, the world has had to face a devastating pandemic caused by SARS-CoV-2. Various studies have identified potential risk factors facilitating the infection, however it has not been demonstrated whether end…

review 2020
Archives of gynecology and obstetrics ·doi:10.1007/s00404-020-05797-8